Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study-Reference-Cited by-同舟云学术

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study

Published:2010-03 Issue:3 Volume:11 Page:275-280
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Thomas David,Henshaw Robert,Skubitz Keith,Chawla Sant,Staddon Arthur,Blay Jean-Yves,Roudier Martine,Smith Judy,Ye Zhishen,Sohn Winnie,Dansey Roger,Jun Susie

Publisher

Elsevier BV

Subject

Oncology

Reference28 articles.

1. Giant cell tumour of bone;Mendenhall;Am J Clin Oncol,2006

2. The histogenesis of giant cell tumour of bone: a model of interaction between neoplastic cells and osteoclasts;Zheng;Histol Histopathol,2001

3. Giant-cell tumour of bone;Szendroi;J Bone Joint Surg Br,2004

4. Surgical treatment and prognostic factors in giant-cell tumour of bone;Szendroi;Acta Chir Orthop Traumatol Cech,2003

5. Malignancy in giant cell tumour;Bullough,2002

Cited by 571 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human Chorionic Gonadotropin Regulates the Smad Signaling Pathway by Antagonizing TGF-β in Giant Cell Tumor of Bone;Recent Patents on Anti-Cancer Drug Discovery;2024-05

2. Sacral Nerve-Sparing Piecemeal Spondylectomy for Giant Cell Tumor of Bone in the Sacrum: Surgical Strategy and Accurate Tumor Location Identification;Spine Surgery and Related Research;2024-01-27

3. THE CURRENT TREATMENT METHODS IN CENTRAL GIANT CELL GRANULOMAS;ADO Klinik Bilimler Dergisi;2024-01-26

4. Denosumab combined with precision radiotherapy for recurrent giant cell tumor of the thoracic spine: a case report and literature review;Frontiers in Neurology;2024-01-04

5. The Risk of Neurological Deterioration While Using Neoadjuvant Denosumab on Patients with Giant Cell Tumor of the Spine Presenting with Epidural Disease: A Meta-Analysis of The Literature;The Spine Journal;2024-01